Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gerrit Jan Wolbink
Comment on ‘Sustained Discontinuation of Infliximab With a Raising-Dose Strategy After Obtaining Remission in Patients With Rheumatoid Arthritis: The RRRR Study, a Randomised Controlled Trial’ by Tanaka Et Al
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Does Intensive Management Improve Remission Rates in Patients With Intermediate Rheumatoid Arthritis? (The TITRATE Trial): Study Protocol for a Randomised Controlled Trial
Trials
Medicine
Pharmacology
Spontaneous Remission of Marginal Zone B Cell Lymphoma in a Patient With Seropositive Rheumatoid Arthritis After Discontinuation of Infliximab-Methotrexate Treatment
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients With IBD After Discontinuation of One-Year Infliximab Therapy
PLoS ONE
Multidisciplinary
A Randomised Controlled Trial of Occupational Therapy for People With Early Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Aggressive Treatment in Early Rheumatoid Arthritis: A Randomised Controlled Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Correction: Discontinuation of Adalimumab After Achieving Remission in Patients With Established Rheumatoid Arthritis: 1-Year Outcome of the HONOR Study: Table 3
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Targeting Ultrasound Remission in Early Rheumatoid Arthritis: The Results of the TaSER Study, a Randomised Clinical Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Discontinuation of Adalimumab After Attaining Disease Activity Score 28-Erythrocyte Sedimentation Rate Remission in Patients With Rheumatoid Arthritis (HONOR Study): An Observational Study
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
